Acorah Software Products - Accounts Production 19.2.450 false true false true No description of principal activity 15 October 2024 31 October 2025 31 October 2025 16018206 Dr Eira Fomicheva iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 16018206 2024-10-14 16018206 2025-10-31 16018206 2024-10-15 2025-10-31 16018206 frs-core:CurrentFinancialInstruments 2025-10-31 16018206 frs-bus:PrivateLimitedCompanyLtd 2024-10-15 2025-10-31 16018206 frs-bus:FilletedAccounts 2024-10-15 2025-10-31 16018206 frs-bus:Micro-entities 2024-10-15 2025-10-31 16018206 frs-bus:AuditExempt-NoAccountantsReport 2024-10-15 2025-10-31 16018206 frs-bus:Director1 2024-10-15 2025-10-31
Registered number: 16018206
Cadernid Psychology Ltd
Unaudited Financial Statements
For the Period 15 October 2024 to 31 October 2025
Balance Sheet
Registered number: 16018206
31 October 2025
£
Current assets 6,446
Creditors: Amounts Falling Due Within One Year (5,528 )
NET CURRENT ASSETS 918
TOTAL ASSETS LESS CURRENT LIABILITIES 918
NET ASSETS 918
CAPITAL AND RESERVES 918

Notes

1. General Information
Cadernid Psychology Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 16018206 . The registered office is Unit E4 Arena Business Centre, Holyrood Close, Poole, Dorset , BH17 7FP.
2. Average Number of Employees
Average number of employees, including directors, during the period was: 2
2
For the period ending 31 October 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Dr Eira Fomicheva
Director
31/03/2026